Skip to main content
FinSpry Logo
FinSpry
LENZ logo
LENZ
(NASDAQ)
LENZ Therapeutics, Inc.
$9.67-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

LENZ Therapeutics (LENZ) Stock Price & Financial Analysis

LENZ Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.13 - $10.08
52-Week High$50.40
52-Week Low$8.25
Open$9.15
Volume698.05K
Average Volume (3M)698.05K
Market Cap275.99M
Shares Outstanding28.54M
Price to Sales (P/S)15.25
Price to Book (P/B)1.38
EV/EBITDA-3.57
Revenue (TTM)17.50M
Net Income (TTM)-58.88M
Free Cash Flow (TTM)-46.16M
EPS (TTM)$-2.06
Profit Margin-336.47%
Operating Margin-388.00%
Return on Equity (ROE)-30.36%
Debt to Equity0.00
50-Day MA$13.28
200-Day MA$26.91
52-Week Change-64.05%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateMar 22, 2024

Frequently Asked Questions About LENZ Therapeutics

What is the current stock price for LENZ?

As of the latest trading session, LENZ stock trades at $9.67. The 52-week range is $8.25–$50.40, with a day range of $9.13–$10.08.

What is the P/E ratio for LENZ?

The P/E ratio (Price-to-Earnings) for LENZ is shown in the Key Statistics section. This valuation metric helps compare LENZ Therapeutics, Inc. to industry peers.

Does LENZ pay dividends?

LENZ Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LENZ?

Based on 2 analysts, the consensus for LENZ is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LENZ?

LENZ Therapeutics's market capitalization is $276.0M, classifying it as a micro-cap company. LENZ Therapeutics operates in the Healthcare sector within the Biotechnology industry.